INTRODUCTION
HF (heart failure) is the leading cause of mortality. A significant proportion of HF patients suffer SCD (sudden cardiac death), which results from aberrant electrical signalling within the heart, leading to arrhythmias and VT (ventricular tachycardia) [1, 2] . In many cases, the cause of SCD can be attributed directly to structural abnormalities caused by HF or other factors. There remain, however, a proportion of individuals who suffer SCD and yet whose hearts present no structural defects [3] . In these patients, VT is believed to be caused by spontaneous Ca 2+ release from the SR (sarcoplasmic reticulum), which leads to membrane depolarization or so-called DADs (delayed afterdepolarizations) [1, 2, 4] .
In addition to normal depolarization-stimulated Ca 2+ release during excitation-contraction coupling, it is known that when the SR Ca 2+ content reaches a critical level, spontaneous SR Ca 2+ release in the form of Ca 2+ waves or Ca 2+ oscillations occurs in cardiac cells in the absence of membrane depolarization. Considering its dependence on the SR Ca 2+ store, we refer to this depolarization-independent Ca 2+ overload-induced SR Ca 2+ release as SOICR (store-overload-induced Ca 2+ release) [5, 6] . A number of mutations have been identified in RyR2 (ryanodine receptor type 2), in familial groups that lower the threshold for SOICR and ultimately cause VT [7] . These mutations give rise to at least two genetic forms of VT: CPVT (catecholaminergic polymorphic ventricular tachycardia) and ARVD2 (arrhythmogenic right ventricular dysplasia type 2) [7] . Patients carrying these mutations often display no symptoms at rest, but under stress or conditions of increased β-adrenergic stimulation, they experience arrhythmias of varying severity. The phosphorylation of RyR2 by PKA (protein kinase A) under stressful conditions via the activation of the β-adrenergic receptor signalling pathway is widely accepted to be an important mediator of these arrhythmias, as well as playing an important role in regulating the channel in non-pathological conditions [8, 9] . PKA has multiple effects on Ca 2+ handling within a myocyte: it phosphorylates a host of proteins that are crucial to the regulation of contraction and relaxation, including L-type Ca 2+ channels and phospholamban, in addition to RyR2. The net result of PKA activation is to increase the SR Ca 2+ load, SR Ca 2+ release, relaxation rate and, ultimately, cardiac output [10] . The molecular effects of PKA phosphorylation on the majority of Ca 2+ -handling proteins have long been established. However, the impact of PKA phosphorylation of RyR2 has remained elusive. We have found recently that the phosphorylation of RyR2 by PKA increases the propensity for Abbreviations used: CaM, calmodulin; CaMKII, Ca 2+ /CaM-dependent protein kinase II; CPVT, catecholaminergic polymorphic ventricular tachycardia; cryo-EM, cryo-electron microscopy; DR, divergent region; DTT, dithiothreitol; FKBP12.6, 12.6 kDa FK506-binding protein; GFP, green fluorescent protein; GST, glutathione transferase; HEK-293, human embryonic kidney; HF, heart failure; MH, malignant hyperthermia; PKA, protein kinase A; RyR, ryanodine receptor; RyR2-wt, wild-type RyR2; SCD, sudden cardiac death; SOICR, store-overload-induced Ca 2+ release; SR, sarcoplasmic reticulum; VT, ventricular tachycardia. 1 Correspondence may be addressed to either of these authors (email liuz@wadsworth.org or swchen@ucalgary.ca).
SOICR by sensitizing the channel to SR luminal Ca 2+ [11] . This effectively reduces the threshold at which Ca 2+ is released, leading to SOICR at a lower SR concentration of Ca 2+ . Which PKA phosphorylation site on RyR2 is responsible for this effect, however, remains controversial.
Marks and co-workers [12] have shown that RyR2 is phosphorylated exclusively at Ser 2808 . They have also shown that the mutation S2808A abolishes the effect of PKA on the channel and the S2808D mutation mimics PKA-phosphorylated RyR2. They also used S2808A-knockin mice to illustrate that PKA cannot phosphorylate any additional sites in RyR2 [13] . [14, 15] . More recently, Ser 2030 has also been identified as a PKA phosphorylation site [16] . Studies comparing the two sites suggest that Ser 2030 is likely to be the more important one in terms of regulation of the activity of the RyR2 channel [17] . These studies show that Ser 2808 is heavily phosphorylated at rest and therefore undergoes only a modest change in phosphorylation in response to PKA activation. In contrast, Ser 2030 displays little basal phosphorylation and undergoes robust phosphorylation under PKA stimulation both in vitro and in vivo. Additionally, mutation of Ser 2030 to phosphomimetic glutamic acid increases the activity of the channel, whereas the equivalent mutation of Ser 2808 has little effect on the activity of the channel [11, 18] . Furthermore, a recent study by Valdivia's group shows that the abolition of the Ser 2808 phosphorylation site in mice does not markedly alter the response of the heart to β-adrenergic stimulation or the single channel properties of RyR2 isolated from these mice [19] . The reasons for these discrepancies regarding PKA phosphorylation of RyR2 are unclear. One possible explanation may be differences in experimental conditions.
To gain structural insight into the mechanism of how the phosphorylation of Ser 2030 by PKA increases the activity of the channel, we determined the three-dimensional location of Ser 2030 in RyR2. We inserted a GFP (green fluorescent protein) tag into the RyR2 molecular sequence after Thr 2023 , adjacent to the Ser 2030 PKA phosphorylation site. The GFP-fusion protein was then purified and subjected to cryo-EM (cryo-electron microscopy) and single-particle image processing. A three-dimensional reconstruction from the particle images shows that the inserted GFP, and hence the Ser 2030 PKA site, is situated in domain 4, a region that may be involved in signal transduction between the transmembrane and cytoplasmic domains.
MATERIALS AND METHODS

Materials
Restriction endonucleases and DNA-modifying enzymes were purchased from New England BioLabs. The anti-RyR and anti-GFP antibodies were obtained from Affinity BioReagents. Soya bean phosphatidylcholine was obtained from Avanti Polar Lipids. CHAPS and other reagents were purchased from Sigma.
Cell culture and DNA transfection HEK-293 (human embryonic kidney) cells were maintained in DMEM (Dulbecco's modified Eagle's medium) as described previously [20] . HEK-293 cells grown on 100-mm-diameter tissue-culture dishes for 18-20 h after subculture were transfected with 12 µg of RyR2-wt (wild-type RyR2), RyR2 T2023−GFP , RyR2(A4860G) or RyR2(A4860G) T2023−GFP cDNA using calcium phosphate precipitation [21] .
Construction of RyR2 T2023−GFP and RyR2(A4860G) T2023−GFP
The cloning and construction of the 15 kb full-length cDNA encoding the mouse cardiac RyR2 sequence has been described previously [22] . The cDNA encoding GFP flanked by glycinerich spacers and AscI sites was obtained by PCR as described previously [23] . The AscI site was introduced into the sequence of the RyR2-wt or RyR2(A4860G) construct after Thr 2023 by overlapextension using PCR. The GFP cDNA flanked by AscI sites was inserted into the full-length RyR2 cDNA. The sequences of all PCR fragments and the orientation of the inserted GFP cDNA were verified by DNA sequencing analysis. 3 H]ryanodine binding to cell lysates were performed as described previously [21] .
HEK-293 cells grown for 24-26 h after transfection were washed three times with PBS plus 2.5 mM EDTA and harvested in the same solution by centrifugation at 700 g for 8 min in an IEC Centra-CL2 centrifuge. The cell pellets were solubilized in a lysis buffer containing 25 mM sodium Pipes (pH 7.2), 140 mM NaCl, 5 mM EGTA, 2.5 mM DTT (dithiothreitol), 1 % CHAPS, 0.5 % phosphatidylcholine and a protease inhibitor mixture (2 mM benzamidine, 4 µg/ml leupeptin, 2 µg/ml pepstatin A, 4 µg/ml aprotinin and 0.75 mM PMSF) and were incubated on ice for 1 h. Insoluble material was removed by centrifugation at 16 000 g twice in a microcentrifuge at 4
• C for 30 min, and the cell lysates were collected. Sucrose (400 mM final concentration) and NaCl (400 mM final concentration) were added to the cell lysates. Glutathione-Sepharose beads (100 µl) containing 400 µg of bound GST-FKBP12.6 fusion protein were added to the cell lysates and incubated at 4
• C with rotation for 2 days. The beads were collected by centrifugation at 5000 g for 8 s and washed four times with lysis buffer containing 0.5 % CHAPS and 0.25 % phosphatidylcholine. The RyR2 proteins were eluted from the beads by incubation with 100 mM glutathione in 25 mM sodium Pipes, 400 mM NaCl, 400 mM sucrose, 1 mM EGTA, 0.2 mM CaCl 2 , 2.5 mM DTT, 0.4 % CHAPS, 0.16 % phosphatidylcholine, 200 mM Tris/Hepes (pH 7.0) and a protease inhibitor mixture, for 15 min. The eluate was divided into twenty 7 µl aliquots, frozen in liquid nitrogen and stored at − 80
• C.
Fluorescent imaging
To detect the green fluorescence of RyR2 T2023−GFP and RyR2(A4860G) T2023−GFP , HEK-293 cells were grown on glass coverslips placed in a 100-mm-diameter tissue culture dish, and transfected with either RyR2(A4860G) T2023−GFP or RyR2 T2023−GFP cDNA as described above. At 24 h after transfection, the coverslips were washed three times with PBS, mounted on a glass slide and visualized with a Zeiss Axioskop2 fluorescent microscope equipped with a FITC filter set (Chroma) using a 40× Neofluar objective (Zeiss).
Cryo-EM and image processing
The expression and purification of RyR2(A4860G) T2023−GFP were carried out as described previously [23] . The purified RyR2(A4860G) T2023−GFP was diluted 5-10-fold with electron microscopy dilution buffer (20 mM sodium Pipes, pH 7.2, 400 mM KCl, 3 mM EGTA, 0.5 % CHAPS, 2 mM DTT and 2 µg/ml leupeptin). Grids were prepared for cryo-EM according to standard methods [25] . Cryo-EM data collection and image processing were performed as described previously [26] .
RESULTS
Insertion of GFP into RyR2 after Thr 2023
To explore the structural basis of the regulation of RyR2 by PKA-dependent phosphorylation, we used GFP as a structural marker to map the three-dimensional location of a major PKA site, Ser 2030 . GFP, flanked by glycine linkers so as to minimize potential structural hindrances [27, 28] , was inserted into the primary amino acid sequence of RyR2 after Thr 2023 ( Figure 1A ), creating the fusion protein RyR2 T2023−GFP . We have shown previously that, barring any major structural changes, the insertion of GFP close to the region of interest is an effective method for mapping the site in three dimensions [23, 24, [29] [30] [31] [32] . To confirm the expression of RyR2 T2023−GFP , HEK-293 cells were transfected with RyR2 T2023−GFP cDNA and imaged using fluorescent microscopy. Figure 1 (B) shows that RyR2 T2023−GFP was expressed readily in HEK-293 cells. The presence of the GFP fluorescence also indicates that the protein was folded correctly, as incorrect folding of GFP eliminates the protein's fluorescence [28, 33] .
Response of RyR2 T2023−GFP to caffeine, ryanodine and Ca
2+
To confirm that the insertion of GFP at Thr 2023 did not cause any major functional or structural changes, we compared the responses of RyR2 T2023−GFP to caffeine and ryanodine with those of RyR2-wt. The response to caffeine was determined by measuring Ca applied ( Figure 2B ), RyR2 T2023−GFP again displayed a reduced sensitivity to activation by caffeine. The EC 50 values for caffeine activation of [ 3 H]ryanodine binding were 7.85 + − 0.44 mM (n = 3) for RyR2 T2023−GFP and 3.44 + − 0.18 mM (n = 6) for RyR2-wt (P < 0.0001). We have shown previously that insertions of GFP into other sites (including the other PKA phosphorylation site, Ser 2808 ) did not significantly alter the sensitivity of the channel to activation by Ca 2+ or caffeine [23, 26, [29] [30] [31] [32] . The apparent reduction in the sensitivity to both Ca 2+ and caffeine activation of RyR2 T2023−GFP indicates that the Ser 2030 PKA site lies in a structurally important region of RyR2.
Generation of RyR2(A4860G) T2023−GFP for three-dimensional reconstruction
We have shown previously that the A4860G mutation, located in the inner pore helix of RyR2, results in more structurally homogeneous receptors as determined by cryo-EM than does RyR2-wt, and so this mutant is superior for three-dimensional mapping to RyR2-wt [26, 34] . The RyR2(A4860G) mutant displays a markedly reduced basal activity and response to luminal Ca 2+ and Ca 2+ overload, suggesting that A4860G stabilizes the closed state of the channel [35] . We therefore inserted GFP after Thr 2023 in the RyR2(A4860G) background, resulting in a GFPtagged RyR2(A4860G), RyR2(A4860G) T2023−GFP . Figure 3 (A) shows that, like RyR2 T2023−GFP , RyR2(A4860G) T2023−GFP is readily expressed in HEK-293 cells. Figure 3 (B) shows that RyR2(A4860G) T2023−GFP displayed the same response to caffeine and ryanodine as did RyR2(A4860G), suggesting that the insertion of GFP into the RyR2(A4860G) background at Thr 2023 does not grossly affect the function of the channel. Figure 3 (B) also illustrates the impact of the A4860G mutation on the activity of the channel. The response to low concentrations of caffeine was markedly reduced, compared with that of RyR2-wt ( Figure 1C) , as reported previously [34] . As with RyR2 T2023−GFP , we characterized RyR2(A4860G) T2023−GFP further by measuring the Ca 2+ -and caffeine-dependence of [ 3 H]ryanodine binding. 
Purification, cryo-EM and three-dimensional reconstruction of RyR2(A4860G) T2023−GFP
To obtain sufficient purified protein for cryo-EM, a large number of HEK-293 cells (80 plates, 10 cm diameter) were transfected with the RyR2(A4860G) T2023−GFP cDNA. Cell lysates were prepared from which RyR2(A4860G) T2023−GFP proteins were purified by affinity chromatography, with GST-FKBP12.6 used as the affinity ligand [24] . The purified protein was analysed by SDS/6 % PAGE and Western blotting ( Figure 5A ). A single high-molecular-mass band was detected in the purified sample of RyR2(A4860G) T2023−GFP . Compared with RyR2(A4860G), the RyR2(A4860G) T2023−GFP band migrated more slowly, as expected, owing to the additional mass of GFP. The RyR2(A4860G) T2023−GFP band was recognized by both the anti-RyR and anti-GFP antibodies ( Figure 5A , panels a and b). On the other hand, the purified RyR2(A4860G) protein was recognized only by the antiRyR antibody ( Figure 5A , panels a and b). The purified RyR2(A4860G) T2023−GFP proteins were diluted in a lipid-and sucrose-free buffer. This was applied to carboncoated electron microscopy grids, which were frozen rapidly in liquid ethane. Images were then recorded using cryo-EM. Figure 5 (B) shows a typical electron micrograph of frozen hydrated RyR2(A4860G) T2023−GFP . Individual apparently intact channels, as compared with previous studies using channels from natural sources, were observed [36, 37] . Through the selection of particles with their 4-fold symmetry axes oriented perpendicular to the carbon support film, and alignment of the images by crosscorrelation, two-dimensional images were formed ( Figure 6) . Overall, the two-dimensional image of RyR2(A4860G) T2023−GFP correlated closely with that of RyR2(A4860G) reported previously [26] , apart from the presence of additional small regions of density. To aid in identifying the subtle differences between RyR2(A4860G) T2023−GFP and RyR2(A4860G), a difference map was created ( Figure 6C ) by subtraction of the structure of RyR2(A4860G) from that of RyR2(A4860G) T2023−GFP . The brightest areas shown in Figure 6 (D) represent protein mass present in RyR2(A4860G) T2023−GFP , but not in RyR2(A4860G). These areas of extra mass were located in regions that likely correspond to domain 3 or domain 4 in the three-dimensional structure of RyR2. Statistical analysis revealed that these regions showed significant differences at the 99.9 % confidence level. These differences almost certainly correspond to the additional mass of GFP, an interpretation confirmed (see below) by more precise mapping of the location of GFP within the threedimensional structure.
Three-dimensional reconstructions were obtained by a projection-matching procedure [32] . The final three-dimensional reconstructions of RyR2(A4860G) and RyR2(A4860G) T2023−GFP were computed from 7591 and 9203 particles respectively. The 4-fold symmetry was enforced in both reconstructions. The final resolution was estimated to be 27 Å (1 Å = 0.1 nm) by Fourier shell correlation (with a cut-off of 0.5) for both RyR2(A4860G) and RyR2(A4860G) T2023−GFP [38] . The difference map was calculated by subtraction of the three-dimensional volume of RyR2(A4860G) from that of RyR2(A4860G) T2023−GFP .
Figures 7(A) and 7(B) show surface representations of the three-dimensional reconstructions of RyR2(A4860G) and RyR2(A4860G) T2023−GFP . The reconstructions reveal the distinctive mushroom shape of RyR2, consisting of a large cytoplasmic assembly with at least ten distinct domains and the smaller transmembrane domain assembly (labelled 1-10 and TA respectively) [36] . As expected from the two-dimensional data, the two reconstructions are highly comparable; however, closer inspection reveals small significant differences. As an aid to better enable visualization of these differences Figure 7 (C) displays the threshold difference map obtained by subtraction of the three-dimensional reconstruction of RyR2(A4860G) from that of RyR2(A4860G) T2023−GFP and superimposing the differences on to RyR2(A4860G). The differences, shown in green, are present on each of the four identical monomers. The difference map shows that the inserted GFP is located in domain 4. We are confident that these differences correspond to GFP, since they were the only significant disparities between the structures obtained for RyR2(A4860G) T2023−GFP and RyR2(A4860G). Moreover, the volume of these additions corresponds to a molecular mass of 28 kDa (assuming a protein density of 1.37 g/cm 3 ) [36] , a value that agrees well with the molecular mass of GFP. Furthermore, the locations of the GFP in the three-dimensional reconstruction are consistent with those in the two-dimensional projections ( Figure 6 ). On the basis of these results, we conclude that the Ser 2030 PKA phosphorylation site is located in domain 4 in the cytoplasmic assembly of the RyR2 structure.
DISCUSSION
We have recently demonstrated that RyR2 is phosphorylated by PKA at two major sites, Ser 2030 and Ser 2808 [16] , and that Ser 2030 , rather than Ser 2808 , is the major site responding to acute β-adrenergic stimulation [17] . In line with these observations, mutation of the Ser 2808 site did not prevent the activation of the channel by PKA [18] . On the other hand, mutation of the Ser 2030 site diminished the effect of PKA [11] . Furthermore, recent in vivo studies have revealed that abolition of the Ser 2808 phosphorylation site in mice has no significant impact on the response of RyR2 to PKA phosphorylation or β-adrenergic stimulation at the singlechannel, cardiac myocyte and intact heart levels [19] . More recently, we have demonstrated that the phosphorylation of RyR2 at Ser 2030 by PKA sensitizes the channel to activation by luminal Ca 2+ and increases the propensity for SOICR [11] . Given the strong correlation between SOICR and triggered arrhythmias, it is likely that the phosphorylation of RyR2 by PKA plays an important role in stress-induced arrhythmias. Taken together, these observations suggest that Ser 2030 is the major site in RyR2 that mediates the effect of PKA-dependent phosphorylation. However, the molecular mechanism by which PKA phosphorylation at Ser 2030 enhances luminal Ca 2+ activation and SOICR is unknown. The objective of the present study was to map the location of Ser 2030 on to the three-dimensional structure of RyR2, in an attempt to gain a better understanding of how the phosphorylation of this site affects the activity of the channel.
Localization of the PKA phosphorylation site Ser 2030 to domain 4 and its functional implication
To map the three-dimensional location of the Ser 2030 site, we inserted GFP into the RyR2 molecular sequence after Thr 2023 . The GFP-tagged RyR2 protein was expressed, purified and imaged using cryo-EM, after which its structure was reconstructed using single particle imaging analysis. The inserted GFP, and hence the Ser 2030 site, was found to lie in domain 4 within the cytoplasmic assembly of the RyR2 structure. Little is known about the corresponding amino acid sequence and functional role of domain 4, since no sites have previously been mapped within this region. On the basis of the RyR1 structure reported recently at ∼ 10 Å (1 Å = 0.1 nm) resolution [39, 40] , domain 4 is situated between domain 4a, which forms a column extending into the transmembrane assembly (channel-gating region), and domain 3, which forms the 'handle' structure that extends into the 'clamp' structure at the corner of the cytoplasmic assembly. Interestingly, the binding sites of previously mapped RyR modulators (e.g. FKBP and CaM), and disease-linked RyR2 mutation sites were located in the clamp and handle structures, suggesting that these structures are important for channel regulation and gating. It has been shown that both the transmembrane and clamp regions undergo large conformational changes between the open and closed states of the channel [41] . It is possible that domain 4 forms part of the signalling pathway, conveying signals to and from the channel-regulating (i.e. the clamp region) and channelgating (i.e. the transmembrane assembly) domains. Accordingly, PKA-dependent phosphorylation of Ser 2030 located in domain 4 may affect the gating of the channel by modulating such communication between the channel-gating and -regulating domains. In this regard, it is of interest to note that the binding site for CaM was localized to a region between domains 3 and 4 [42] , suggesting that the interaction between domains 3 and 4 may be another critical area of modulation. In support of this view, the sites of imperatoxin A binding [43] and divergent region I [23] were also mapped to this region.
The functional significance of domain 4 was indicated further by the observation that the insertion of GFP into this domain altered the response of the RyR2 channel to Ca 2+ and caffeine. We have previously inserted GFP into multiple regions within the primary sequence of RyR2 [23, 24, 26, [29] [30] [31] [32] . None of these insertions has resulted in any significant alterations in the channel's function. The insertion of GFP after Thr 2023 , however, resulted in a channel with a reduced sensitivity to both Ca 2+ and caffeine activation, despite the fact that GFP was flanked with glycine spacers, in order to ease the accommodation of the moiety and to minimize potential perturbations to the structure. Marks and co-workers [44] showed that the phosphorylation of RyR2 by PKA induced dissociation of FKBP12.6 from the channe. They proposed that the phosphorylation of Ser 2808 by PKA was directly responsible for this dissociation, through an electrostatic repulsion between the phosphorylated Ser 2808 and a negatively charged residue in the FKBP12.6 molecule. However, we have recently obtained direct structural evidence indicating that this is not the case [26] . We found that the Ser 2808 PKA site was located in domain 6, far away from the previously mapped FKBP12.6-binding site in domain 9 near its junction with domain 3, indicating that a direct interaction between FKBP12.6 and Ser 2808 is unlikely. In the present study, we have localized the other PKA site in RyR2, Ser 2030 , to domain 4, which is also not in close proximity to the FKBP12.6-binding site. Again, and as for Ser 2808 , a direct interaction between Ser 2030 and FKBP12.6 is unlikely, which is consistent with our previous observation that stoichiometric phosphorylation of recombinant or native RyR2 by PKA does not dissociate FKBP12.6 [45] .
A proposed model for RyR2 subunit organization
RyRs are tetrameric structures composed of four identical subunits. Three-dimensional reconstruction of RyRs has provided increasingly detailed information about the organization of the internal cytoplasmic domains and the transmembrane assembly [39, 40] . However, the best resolution to date (∼ 10 Å) is still too low to unambiguously reveal the organization and boundaries of the RyR subunits. Alternatively, we may be able to gain some clues to the organization of its subunits by mapping specific residues or sequences that are distributed along the linear sequence of RyR2 on to the three-dimensional structure. To this end, a number of residues or sequences have been mapped in the three-dimensional structure of RyR (Figure 8 ). These include: (1) the N-terminus, mapped near to the centre of the clamp in a region surrounded by domains 5, 6, 9 and 10 [32]; (2) Ser 437 , located within the N-terminal MH (malignant hyperthermia)/CPVT region, mapped between domains 5 and 9 [29] [47] . On the basis of the distribution of these mapped residues or sequences, the linear amino acid sequence of RyR can be divided into three segments (Figure 8 ): (I) residues 1-1874, encompassing green circles 1-6; (II) residues 2023-2801, including green circles 7-10, and (III) residues 3614-4554, encompassing green circles 11-13. As seen in Figure 8(A) , the Nterminal segment (residues 1-1874, green circles 1-6) is located at one side of the clamp structure that forms each of the corners of the cytoplasmic assembly, whereas the central segment (residues 2023-2801, green circles 7-10) is located in domains 4 and 6, which forms the other side of the clamp structure. The Cterminal segment (residues 3614-4554, green circles 11-13) is located in domain 3, which forms the side of the cytoplasmic assembly. The mapped residues or sequences within each segment are closely grouped, suggesting that these segments are likely to form multiple interconnected domains. However, how these three segments are linked together to form one subunit in the threedimensional structure of the tetrameric RyR2 is unclear. At present, the results of our three-dimensional mapping studies do not unambiguously distinguish between these three models of subunit organization, thus further three-dimensional mapping studies are needed. For instance, three-dimensional localization of residues between residues 1874 (green circle 6 in domain 9) and 2023 (green circle 7 in domain 4) ( Figure 8A, panel b) should provide critical information on whether domain 9 is connected to domain 4 via domain 3, as in the first model ( Figure 8B, panel a) , or via domains 5 and 6, as in the second and third models ( Figure 8B, panels b and c) . In other words, three-dimensional mapping of residues 1874-2023 should suffice to separate the first model from the second and third models. Similarly, threedimensional localization of residues between residues 2801 (green circle 10 in domain 6) and 3614 (green circle 11 in domain 3) should provide clues to whether domain 6 is connected to domain 3 via domain 5, as in the second model ( Figure 8B, panel b) , or via domain 4, as in the third model ( Figure 8B, panel c) . Hence, three-dimensional mapping of residues 2801-3614 should allow us to choose between the second and third models, if the mapping of residues 1874-2034 ruled out the first model.
Recently, as noted above, a three-dimensional RyR structure has been reconstructed at ∼ 10 Å [39] . Analysis of the density distribution of multiple cross-sections of the RyR structure revealed extensive interconnectivity among domains 2, 2a, 3, 4, 4a and 5 within the structural section outlined by the blue broken line ( Figure 8B, panel a) . The analysis also revealed the existence of some clear separations of mass along the blue broken line ( Figure 8B, panel a) . This pattern of density distribution suggests that the domains outlined by the blue broken line are likely to be interconnected. On the basis of these putative internal mass arrangements and on our three-dimensional localizations of various residues, we propose that each structural section outlined by the blue broken line in panel a of Figure 8 (B) represents one subunit in the tetrameric structure of RyR2. Clearly, more investigations are required to test this working hypothesis on subunit organization, and to unravel the intra-and inter-subunit interactions within the tetrameric structure of RyR2.
In summary, in the present study, we have localized the Ser
2030
PKA phosphorylation site on to domain 4 in the three-dimensional structure of RyR2. The three-dimensional mapping of the Ser
PKA site not only reveals new insight into the mechanism of RyR2 regulation by phosphorylation, but also provides a framework for future investigations of the RyR2 subunit organization and interdomain and intersubunit interactions.
